Exact Sciences Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EXAS Nasdaq 2836 www.exactsciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Exact Sciences Corporation

3 Cash-Producing Stocks We Approach with Caution - Mar 6th, 2026 5:19 am
Cancer tests are becoming more precise and guiding pharma R&D - Mar 5th, 2026 1:00 am
CSLLY or EXAS: Which Is the Better Value Stock Right Now? - Mar 4th, 2026 9:40 am
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year - Mar 4th, 2026 7:00 am
Is Exact Sciences (EXAS) Pricing Reflect Long Term Cancer Screening Growth Potential - Mar 3rd, 2026 10:13 am
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - Mar 3rd, 2026 8:00 am
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval - Feb 27th, 2026 2:05 pm
Alpine Loads Up on Air Lease With 1.07 million Shares Bought in Q4 - Feb 25th, 2026 4:25 pm
Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting - Feb 23rd, 2026 10:07 am
Exact Sciences Stockholders Approve Acquisition by Abbott - Feb 20th, 2026 2:05 pm
Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up - Feb 19th, 2026 6:16 am
3 Unpopular Stocks We Approach with Caution - Feb 18th, 2026 9:40 pm
Assessing Exact Sciences (EXAS) Valuation After Strong Recent Share Price Momentum - Feb 17th, 2026 9:36 pm
How The Abbott Offer Is Rewriting The Story For Exact Sciences (EXAS) - Feb 17th, 2026 6:08 pm
How Investors May Respond To Exact Sciences (EXAS) Narrowing Losses And Oncotype DX Milestone - Feb 17th, 2026 3:11 am
CSLLY vs. EXAS: Which Stock Is the Better Value Option? - Feb 16th, 2026 9:40 am
3 Overrated Stocks That Concern Us - Feb 15th, 2026 9:46 pm
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates - Feb 13th, 2026 3:15 pm
Exact Sciences: Q4 Earnings Snapshot - Feb 13th, 2026 2:21 pm
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results - Feb 13th, 2026 2:05 pm